SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-24-008908
Filing Date
2024-03-05
Accepted
2024-03-05 16:21:08
Documents
15
Period of Report
2024-03-01
Items
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ardx-20240301.htm   iXBRL 8-K 26229
5 ardx-20240301_g1.jpg GRAPHIC 2570
  Complete submission text file 0001628280-24-008908.txt   162582

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ardx-20240301.xsd EX-101.SCH 1901
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ardx-20240301_lab.xml EX-101.LAB 24851
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ardx-20240301_pre.xml EX-101.PRE 13046
16 EXTRACTED XBRL INSTANCE DOCUMENT ardx-20240301_htm.xml XML 2892
Mailing Address 34175 ARDENWOOD BLVD. FREMONT CA 94555
Business Address 34175 ARDENWOOD BLVD. FREMONT CA 94555 510-745-7047
ARDELYX, INC. (Filer) CIK: 0001437402 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36485 | Film No.: 24720765
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)